Articles about Russian Direct Investment Fund
13 Jul 2021India
The Serum Institute of India (SII) will begin producing the Russian COVID-19 vaccine, Sputnik V, from September, the Russian Direct Investment Fund (RDIF) announced today.
06 Jul 2021India
Morepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, the Russian Direct Investment Fund (RDIF) and the drug firm said in a statement on Tuesday.
13 Apr 2021India
Sputnik V, the Russia-made coronavirus vaccine, will be manufactured in India by five pharmaceutical firms. It is estimated that 850 million doses will be produced yearly.
19 Mar 2021World
Stelis Biopharma, the biopharmaceutical arm of Bengaluru-based Strides Pharma Science, will be making and supplying at least 200 million doses of the Sputnik V vaccine, the Russian coronavirus vaccine currently awaiting emergency use approval in India.
22 Dec 2020World
Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.
18 Dec 2020Technology
India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.
02 Dec 2020World
Russian President Vladimir Putin on Wednesday ordered authorities to start mass voluntary vaccinations for COVID-19.
27 Nov 2020Technology
India will produce over 100 million doses a year of the Russian COVID-19 vaccine Sputnik V starting 2021, under an agreement between the Russian Direct Investment Fund (RDIF) and Hyderabad-based Hetero Biopharma, Hindustan Times reported.
24 Nov 2020Technology
The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.
22 Nov 2020Technology
Russia's COVID-19 vaccine candidate, called Sputnik V, is expected to start human trials in India soon.
25 Oct 2020India
Phase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.
08 Oct 2020India
India's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.
18 Sep 2020Technology
Sputnik V, the COVID-19 vaccine developed and approved by Russia, has shown side effects in some trial volunteers.
16 Sep 2020India
In a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.
21 Aug 2020World
Russia has been in the headlines for its two-month-tested 'Sputnik V' COVID-19 vaccine.
09 Aug 2020World
Russian health officials are set to register a vaccine candidate for the novel coronavirus disease, COVID-19, as early as this week.